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ABSTRACT 
 
   Purpose: To investigate the impact of the time factor on the locoregional control in combined 
treatment (surgery and postoperative radiotherapy) in patients with advanced laryngeal cancer. 
   Materials and Methods: Between January 1993 and December 1996, 254 patients with pT3 or pT4 
and pN0- pN2 laryngeal cancer were treated by surgery and postoperative radiotherapy (RT). The me-
dian age of patients was 56.3 years (range: 30 -70 years). The analyzed group consisted of 236 males 
(92%) and 18 females (8%). In all cases total laryngectomy was performed. 196 out of 254 patients 
underwent homolateral neck dissection and 58 out of 254 bilateral neck dissection. RT began 45 days 
postoperatively (range: 22 to 78 days) and continued for 47 days (range: 40-74 days). The primary 
tumour bed was irradiated to the median total dose of 61.2 Gy (range: 57 – 64 Gy) and all regional 
lymph nodes were treated in all patients to a dose of 50 Gy. Postoperative RT was indicated in case 
of close postoperative margins at the tumour site or pathological status of lymph nodes described 
as pN1 or pN2. Univariate and multivariate analyses were used to determine the predictors 
for locoregional failure. The following factors were studied for their prognostic importance of locoregio-
nal outcome: the overall treatment time (OTT), radiotherapy treatment time (RTT), the interval 
between surgery and the beginning of radiotherapy, age, sex, pT and pN categories.  
   Results: The actuarial 5-year overall survival rate was 49%, the actuarial loco regional control rate 
was 70%. The univariate analysis, using a log-rank test indicated that prolongation of the overall 
treatment time (OTT), the time of radiotherapy (RTT), the interval time between surgery and radio-
therapy, and the pN status were predicted for the loco regional control of postoperative radiotherapy. 
The multivariate analysis using Cox proportional hazard model indicated that only RTT, OTT, and the pa-
thological status of lymph nodes were independent prognostic factors for the loco regional control.  
   Conclusions: The analysis showed that the prolongation of the overall treatment time of the com-
bined modality (OTT) and the time of radiotherapy course (RTT) were independent prognostic time 
factors correlated with lower loco regional control.  
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INTRODUCTION 
 
   In advanced laryngeal cancer, combined 
treatment consisting of surgery and post-
operative radiotherapy is a standard treat-
ment modality in many centers across 
the world [1,2,3,4,5,6]. Despite the fact 
that the margins of resection are described 
as negative, postoperative radiotherapy 
in head and neck cancer is usually recom-
mended due to the significant relapse rate 
in T3 or T4 tumours and N1 or N2 or N3 
neck disease [7,8].  
   Numerous data from literature indicate 
that the protraction of radiotherapy alone 
or in postoperative modality caused a de-
crease in local and/or regional outcome 
of treatment [9,10,11]. The accelerated 
repopulation of clonogenic tumour cells 
accounts the negative influence of the time 
factor [12]. The importance of the total 
time of combined treatment measured 
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from surgery (first day) to the end of radio-
therapy (the last day of treatment), the ti-
me interval between surgery and the be-
ginning of radiotherapy, and the time of ra-
diotherapy in laryngeal cancer has not 
been as yet precisely determined.  
   The purpose of this study is to evaluate 
the effect of the time factor in postopera-
tive radiotherapy, defined as the overall 
treatment time, the time between surgery 
and the beginning of radiotherapy, and 
the time of radiotherapy on the locoregio-
nal outcome of combined treatment in ad-
vanced laryngeal cancer.  
 
MATERIALS AND METHODS 
 
   254 patients with stage III or IV (1992 
AJCC staging system) histologically pro-
ven squamous cell carcinoma of the larynx 
were treated by a surgery and a postope-
rative radiotherapy between January 1993 
and December 1996 at the Department 
of Otolaryngology, University School of Me-
dical Sciences in Poznań and the Depart-
ment of Radiotherapy at the Great Poland 
Cancer Center in Poznań. The standard 
evaluation prior to surgery included: a com-
plete history, physical examination, chest 
radiographs, ultrasonography of the neck, 
complete blood counts and serum che-
mistry. Computed tomography (CT) 
of the larynx and pharynx was performed 
almost in 50% of patients. The patients’ 
clinical and pathological staging was per-
formed according to the recommendation 
of the American Joint Committee on Can-
cer (1992) [13]. Patients’ characteristics 
are shown in Table 1.  
 
Tab. 1. Patient’s characteristics according to stage of disease. 
 
Variables Number of patients 
male 236 (93%) 
female 18 (7%) 
pT3 179 (70%) 
pT4 75 (30%) 
pN0 132 (52%) 
pN1 96 (38%) 
pN2 26 (10%) 
 
Abbreviations used in the table: 
p – pathological classification 
Surgery 
 
   Total laryngectomy with homolateral 
or bilateral lymph adenectomy of the neck 
has been performed. 196 patients 
undergone homolateral neck dissection 
and 58 patients bilateral neck dissection. 
Before surgery no patient had tracheo-
stomy. Only patients with good perfor-
mance status (Karnofsky scale as 70 and 
over) were included in the study. Patients 
with advanced stages of the disease 
in lymph nodes higher than pN2 and tu-
mour stage lower than pT3 were excluded 
from the analysis due to different progno-
sis from other categories (pT3 – pT4 and 
pN0 – N2). 
 
Radiotherapy 
 
   Charts of all patients were reviewed. 
Patients were treated with Co60 or 6 MV 
X-rays with the application of lateral por-
tals encompassing the tumour bed and all 
neck lymph nodes. The conventional post-
operative radiotherapy was given 5 times 
a week at dose of 2 Gy per fraction to 
the median total dose of 61.2 Gy (range: 
57 – 64 Gy) to the tumour bed. The dose 
was calculated for the midline of the neck. 
A shrinking field technique with shielding 
of the spinal cord after dose of 44 Gy was 
introduced and then additional irradiation 
of the posterior lymph nodes with 9 MeV 
electrons to the dose of 50 Gy was con-
tinued. The lower neck lymph nodes were 
irradiated electively with an anterior field 
to a dose of 50 Gy.  
   The median time interval between surge-
ry to the beginning of RT was 45 days. 
Patients after surgery waited for the begin-
ning of RT due to the time needed for 
the pathological evaluation and the waiting 
time for RT at our center, which was about 
3 - 4 weeks. The median time of the RT 
course was 47 days (range: 40-74 days). 
During radiotherapy some gaps were ob-
served because of acute mucositis, con-
current diseases, breakdown of the thera-
peutic machine, problems with the trans-
port of patients, and public holidays. 
The median time of the overall combined 
treatment time (OTT) was 92 days (range: 
65 - 131 days). Patients’ characteristic re-
garding the time factor are shown in Table 2. 
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Tab. 2. The time factor in the analysed group of patients. 
 
Variables Days/Number of patients (pts) 
OTT   92 days (range 65 – 131) 
interval between surgery and RT   45 days (range 22 – 78) 
duration of RT   47 days (range 40 – 74) 
interval time longer than 50 days 177 (69%) pts 
RT duration longer than 44 days   73 (28%) pts 
OTT longer than 90 days 141 (55%) pts 
OTT longer than 100 days   76 (30%) pts 
 
Abbreviations used in the table: 
RT – radiotherapy 
OTT – overall treatment time 
pts – patients 
 
 
The follow-up 
 
   After the completion of radiotherapy, all 
patients were evaluated for a local-regio-
nal control and complications, and survival 
by a multidisciplinary team of a radiation 
oncologist and a surgeon over 2-month in-
tervals for the first 2 years, and at 6-month 
intervals for three and more years. Gene-
rally, 52 patients were lost from the follow-
up for unknown reasons. 
 
Statistical methods 
 
   The endpoint used in this study was 
the loco regional control (LRC) for the pa-
tients analyzed. Patients during the follow-
up were considered to be failures when 
a recurrence either in the primary tumour 
bed or in the regional lymph nodes occu-
rred, or in a case when distant metastases 
with regional failure were found concurren-
tly. Patients who developed isolated dis-
tant metastases without any local-regional 
failure were censored at the time of the 
event. Patients who died of a concurrent 
disease without any evidence of a local-
regional failure were censored at the time 
of the last follow-up.  
   The time factor was divided into follo-
wing groups (categorical variables): the in-
terval time between the surgery and 
the RT (less than 50 days and more than 
50 days), the time of RT (below 44 days 
vs. over 44 days), the overall treatment 
time (up to 90 days vs. over 90 days 
and up to100 days vs. over 100 days). 
The time factor values (OTT, RT time, 
and the waiting time) were also analyzed 
as continuous variables. 
   The actuarial loco regional control (LRC) 
rate curves were estimated by the method 
of Kaplan and Meier [14]. Actuarial LRC 
rates were analyzed by univariate me-
thods (the comparison of survival curves), 
which were performed using a log rank 
test [15]. A multivariate analysis was ba-
sed on the Cox proportional hazard model 
including the following factors: age, sex, 
pathological nodal status, RTT, and inter-
val time between surgery and radiothe-
rapy.  
 
RESULTS 
 
   The median follow-up was 4.5 years. 
The actuarial 5-year overall survival was 
49%, the actuarial LRC rate for the entire 
group was 70% (Fig. 1). Following si- 
tes of the LRC relapses such as local 
(n = 8 patients), regional and regional 
with the presence of distant metastases 
(n = 78 patients) were observed.  
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       Fig. 1. The actuarial 5-year loco regional control for all 254 patients. 
 
 
 
   Tumour stage (pT3, pT4), patients’ age, 
sex, the interval between surgery and 
the RT less than 50 days, and the RT time 
shorter than 44 days were not connected 
with a worse outcome of treatment. 
   The actuarial 5-year LRC rates in the 
group of patients treated by surgery and 
post-operative radiotherapy for pT3 and 
pT4 stage were 68%, and 72%, respec-
tively (p = 0.2).  
   The univariate analysis (log-rang test) 
revealed that the involvement of lymph 
nodes (pN0 vs. pN1-2) was associated 
with worse results of combined treatment. 
In patients without any involvement 
of lymph nodes (pN0) the estimated 5-year 
LRC rate was 76%, but in the group 
of patients with metastases in lymph 
nodes (pN+) the LRC rate was 64%. 
The comparison of the two estimated 
curves for the status of lymph nodes was 
found to be statistically significant 
(p = 0.007, log-rang test). 
   Patients with the interval time between 
S and RT more than 50 days had the 5-ye-
ar LRC rate 68% as compared with 72% 
for those with the time interval less than 
50 days (p = 0.04). In the group of patients 
with involvement of lymph nodes (pN+) 
the negative influence of the prolongation 
of the waiting time (the time interval 
between surgery and the radiotherapy) 
on the outcome was more pronounced 
(p = 0.007) than in the group of patients 
(pN0) without metastases to the lymph 
nodes (p = 0.39).  
   The prolongation of the time of the RT 
beyond 44 days was connected with an in-
crease in number of loco regional failures 
(p = 0.002, log-rang test). 
   The overall time of the combined treat-
ment (OTT) longer than 90 days was cor-
related with the increased loco regional fa-
ilure (p = 0.07, log-rang test). In the group 
of patients with the OTT longer than 
100 days (n = 76) the 5-year LRC rate was 
63% compared with 77% in patients with 
the OTT shorter than 100 days p = 0.0009) 
(Fig. 2). 
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Fig. 2. The actuarial the 5-year locoregional control rate for the entire group of patients (n = 254) according to overall treatment 
of combined time. 
 
 
 
   The results of the multivariate ana- 
lysis are shown in Table 3. The data 
in the table indicated that the pathological 
status of lymph nodes, the overall tre-
atment time, and the time of radiotherapy 
were independent variables which had 
a great effect on the results of treatment. 
On the other hand, such variables as 
pT3/pT4, the interval time between sur-
gery and radiotherapy, age, and sex were 
not independent prognostic factors for loco 
regional control in postoperative radiothe-
rapy.  
 
Tab. 3. The multivariate analysis for locoregional failure: the proportional Cox hazard model. 
 
Variables hazard ratio CI [95%] p 
T stage (pT3/pT4) 0.9         – ns; 0.69 
N stage (pN0/pN1-2) 1.34 1.29 – 1.39 0.035 
Interval time (days) 1.01         – ns; 0.04 
Time of RT (44<days/ 44>days) 1.39 1.24 – 1.54 0.016 
Age (years); <60/>60 0.85         – ns; 0.51 
Sex (male/female) 1.003         – ns; 0.18 
 
CI – confidence interval 
ns – non significant 
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DISCUSSION 
 
   During the last few years the duration 
of radiotherapy has been demonstrated 
to be one of the most important prognostic 
factor in radiotherapy in head and neck 
cancers.  
   Our analysis was shown that the pro-
longation of the overall combined treat-
ment time (from surgery to the end of ra-
diotherapy) was associated with decrea-
sed loco regional control in advanced 
laryngeal cancer. Prolongation of both 
the overall treatment time and the time 
of radiotherapy (RTT) let to the decrease 
in locoregional control.  
   Numerous retrospective studies have 
indicated that the prolongation of RT alone 
in head and neck cancer had a negative 
effect on the outcome of treatment [10,11, 
12,16,17,18]. The risk of failure connected 
with one additional day of irradiation time 
(protraction) in radiotherapy alone resulted 
in average loss of locoregional control by 
approximately 1 - 2%. The main factor 
responsible for such a negative adverse is 
the accelerated repopulation of clonogenic 
cells [19]. The definition of time in this 
work was based on the concept that the 
time factor should be considered as a total 
“package” in the context of accelerated 
repopulation [16,17,18].  
   Generally, the analysis of the time factor 
in postoperative radiotherapy is more com-
plicated than in radiotherapy alone beca-
use of many unknown factors such as 
the amount of cancer cells prior to radio-
therapy, post surgery changes in the blood 
flow in the operative field, and infla-
mmatory cytokines which may influence 
the results of radiotherapy. After surgery 
the amount of cancer cells may differ 
in a broad spectrum and in some patients 
no cancer cells can be expected (no RT 
is needed), but on the other hand, the tu-
mour bed or/and the entire network 
of lymph nodes of the neck (a microscopic 
disease) may contain 109 of cancer cells 
[20].  
   Inaccurate postoperative pathological 
evaluation of the margins of resections, 
particularly in patients with advanced dise-
ase (pT4) is another problem. According 
to Parsons et al. [8] and Looser et al. [21] 
in advanced head and neck cancer 
the evaluation of surgical margins in all 
possible directions is a great challenge 
for a pathologist, and such an evaluation 
in approximately of 40% of all cases is 
usually inaccurate. It is worth emphasizing 
that in this series recurrences in the pri-
mary tumour bed were observed only 
in 8 out of 254 patients (3%). The main 
field of recurrences were regional lymph 
nodes, and thus the more efficient treat-
ment in this area may result in improve-
ment in the outcome of treatment.  
   The third factor, which makes it difficult 
to evaluate the effect of the time factor on 
the outcome of postoperative treatment is 
the fact that accelerated repopulation is 
probably limited mainly to surgery fields 
(tumour bed and the area of lymph nodes 
dissection).  
   In our material, the high risk of subcli-
nical involvement of lymph nodes was 
the main indication for the postoperative 
radiotherapy. Seventy-eight out of 254 pa-
tients had relapses in the neck and 50% 
of them relapsed within the first two years 
of the follow-up after the treatment com-
pletion. Another problem which occurred 
in our analysis was the loss of 52 patients 
from the follow-up which is common 
in the group of patients with an advanced 
stage of head and neck cancer.  
   We have excluded from the analysis 
a group of patients who represented a ve-
ry advanced stage of the disease in lymph 
nodes established as N3 due to a very 
poor prognosis in this group. On the other 
hand, we also excluded patients with a low 
risk of local relapse (pT2). The main rea-
son was enhancement of the homogeneity 
patients and treatment (surgery, dose 
of radiotherapy). The locoregional control 
rate (LRC) for an evaluation the effect 
of the time factors on the results of treat-
ment in a combined treatment modality 
was chosen, because it estimates more 
properly local efficiency of radiotherapy 
than the overall survival. A simple com-
parison of the results of treatment based 
on the overall survival is problematic 
in head and neck cancer because 
of the high frequency of comorbidity illness 
and a high rate of the second malignancy 
due to a strong smoking abuse. In the po-
pulation of patients with advanced stage 
of laryngeal cancer even after successful 
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treatment the risk of occurrence of a new 
site of origin of cancer disease in other or-
gans like the lungs, esophagus is still high.  
   In the first phase of our analysis the log-
rank test (univariate analysis) has shown 
that the prolongation of OTT, RTT, the in-
terval time between surgery and radiothe-
rapy, and involvement of lymph nodes we-
re associated with a decrease in LRC rates.  
   The multivariate analysis (Cox proportio-
nal hazard model) indicated that the pro-
longation of the OTT and the time of RTT, 
and involvement of lymph nodes constitu-
ted independent prognostic factors for lo-
coregional control. The time interval be-
tween surgery and radiotherapy was im-
portant, but multivariate analysis did not 
confirm this is an independent prognostic 
factor for combined treatment. A more ne-
gative influence on the results of treatment 
was due to the protraction of the radiothe-
rapy (RTT) rather than to the time interval 
between surgery and radiotherapy. Similar 
observations made Parson et al. [8] were 
based on a study of postoperatively irra-
diated patients with cancer of the oral ca-
vity. According to this report the attention 
should be focused on the time interval be-
tween surgery and irradiation and the time 
of radiotherapy. 
   Finally, we can conclude that patients 
with more aggressive biology of the dise-
ase (pN2, infiltration of lymph node cap-
sule) and advanced stage needed a more 
intensive treatment such as accelerated 
radiotherapy or concurrent radio-chemo-
therapy [22,23,24]. 
 
CONCLUSIONS 
 
   The prolongation of the overall treatment 
time of a combined modality leads to a de-
crease in the locoregional control in a group 
of patients with advanced laryngeal can-
cer. This negative effect was a result was 
an effect of the prolongation of both 
the time of adjuvant RT and the time 
interval between surgery and RT, the im-
pact of the latter factor being smaller. 
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